Killian Meara

The E. Stanley Crawford Critical Issues Forum at VAM 2026 focused on innovations in vascular surgery and served as the setting for the launch of

Disparities in vascular access outcomes are driven less by biology and more by inequities in education and communication, according to Karen Woo, MD, PhD, professor of surgery at the UCLA David Geffen School of Medicine.

During the Annual Business meeting at VAM 2026, the Society for Vascular Surgery (SVS) announced it elected William Shutze, MD, as the incoming vice president and Bernadette Aulivola, MD, as the new treasurer.

During the keynote address at VAM 2026, author and political commentator Michael Smerconish argued that one of the greatest challenges facing the

Should vascular surgeons receive additional certification in specific areas of practice?

During his presidential address at VAM 2026, Keith Calligaro, MD, called on vascular surgeons to think beyond today's clinical challenges and outlined

During his presidential address at VAM 2026, Keith Calligaro, MD, called on vascular surgeons to think beyond today’s clinical challenges and outlined a vi

“The artery is ours and it should be all of it,” said Lily Johnston, MD. “Trying to reroute the blood flow without changing what runs through it is

Genetic variants that reduce the effectiveness of clopidogrel may increase the risk of heart attack and stroke in patients undergoing peripheral artery disease (PAD) interventions, according to research presented at VAM 2026.

Innovation in vascular surgery goes beyond new devices and procedures. It also requires new approaches to advocacy in a health care system increasingly shaped by consolidation, workforce shortages and shifting employment models.